BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Celgene International Sárl Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients

  October 25, 2012

   · 

  1 min read
• Business

  Anthera Pharmaceuticals, Inc. Reports 2012 Third Quarter Financial Results and Provides Clinical Progress Update

  October 25, 2012

   · 

  1 min read
• Pharm Country

  Vasomedical Inc. Announces Application for Listing on the OTC Bulletin Board (“OTCBB”)

  October 25, 2012

   · 

  1 min read
• Business

  NeuroMetrix, Inc. Reports Q3 2012 Results

  October 25, 2012

   · 

  1 min read
• Business

  Chesapeake PERL, Inc. to Produce Nerve Agent Bioscavenger for DTRA

  October 25, 2012

   · 

  1 min read
• Business

  XenoPort, Inc. Reports Third Quarter Financial Results

  October 25, 2012

   · 

  1 min read
• Business

  Dyax Corp. Announces Third Quarter 2012 Financial Results

  October 25, 2012

   · 

  1 min read
• GlaxoSmithKline Backs Thrasos Therapeutics With $35 Million for Acute Kidney Injury Tx Research

  October 25, 2012

   · 

  4 min read
• Lone Star Bio

  Access Pharmaceuticals Announces Private Placement Financing

  October 25, 2012

   · 

  2 min read
• Drug Development

  Novelos Therapeutics, Inc. Announces Enrollment of First Patient in Solid Tumor Imaging Trial With I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center

  October 25, 2012

   · 

  6 min read